Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Michael Schmidt is an analyst at Guggenheim. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/18/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/18/2025 | MRUS | Buy Now | Merus | $46.39 | 134.96% | Michael Schmidt58% | $109 → $109 | Reiterates | Buy → Buy | Get Alert |
| 03/18/2025 | INCY | Buy Now | Incyte | $60.00 | 53.33% | Michael Schmidt58% | $92 → $92 | Downgrade | Buy → Neutral | Get Alert |
| 03/13/2025 | ARVN | Buy Now | Arvinas | $8.36 | 282.67% | Michael Schmidt58% | $57 → $32 | Maintains | Buy | Get Alert |
| 03/12/2025 | LEGN | Buy Now | Legend Biotech | $37.88 | — | Michael Schmidt58% | — | Reiterates | Neutral → Neutral | Get Alert |
| 03/10/2025 | AVBP | Buy Now | ArriVent BioPharma | $19.50 | 130.77% | Michael Schmidt58% | → $45 | Initiates | → Buy | Get Alert |
| 02/26/2025 | ORIC | Buy Now | ORIC Pharmaceuticals | $7.63 | — | Michael Schmidt58% | — | Reiterates | Buy → Buy | Get Alert |
| 02/24/2025 | CMPX | Buy Now | Compass Therapeutics | $2.32 | 417.24% | Michael Schmidt58% | → $12 | Initiates | → Buy | Get Alert |
| 02/12/2025 | MRUS | Buy Now | Merus | $46.39 | — | Michael Schmidt58% | — | Reiterates | Buy → Buy | Get Alert |
| 02/12/2025 | EXEL | Buy Now | Exelixis | $36.36 | 15.51% | Michael Schmidt58% | $42 → $42 | Reiterates | Buy → Buy | Get Alert |
| 02/12/2025 | ARVN | Buy Now | Arvinas | $8.36 | 581.64% | Michael Schmidt58% | $57 → $57 | Reiterates | Buy → Buy | Get Alert |
| 02/10/2025 | ORIC | Buy Now | ORIC Pharmaceuticals | $7.63 | — | Michael Schmidt58% | — | Maintains | Buy | Get Alert |
| 01/24/2025 | VSTM | Buy Now | Verastem | $6.50 | — | Michael Schmidt58% | — | Reiterates | Buy → Buy | Get Alert |
| 01/22/2025 | IPSC | Buy Now | Century Therapeutics | $0.61 | — | Michael Schmidt58% | — | Reiterates | Buy → Buy | Get Alert |
| 01/22/2025 | EXEL | Buy Now | Exelixis | $36.36 | — | Michael Schmidt58% | — | Reiterates | Buy → Buy | Get Alert |
| 01/08/2025 | SWTX | Buy Now | SpringWorks Therapeutics | $49.65 | 57.1% | Michael Schmidt58% | $80 → $78 | Maintains | Buy | Get Alert |
| 01/07/2025 | EXEL | Buy Now | Exelixis | $36.36 | 15.51% | Michael Schmidt58% | $33 → $42 | Maintains | Buy | Get Alert |
| 12/12/2024 | ARVN | Buy Now | Arvinas | $8.36 | — | Michael Schmidt58% | — | Reiterates | Buy → Buy | Get Alert |
| 12/12/2024 | ADCT | Buy Now | ADC Therapeutics | $1.83 | 446.45% | Michael Schmidt58% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 12/11/2024 | BPMC | Buy Now | Blueprint Medicines | $89.59 | — | Michael Schmidt58% | — | Reiterates | Buy → Buy | Get Alert |
| 12/06/2024 | TARA | Buy Now | Protara Therapeutics | $4.33 | 361.89% | Michael Schmidt58% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
| 12/05/2024 | MRUS | Buy Now | Merus | $46.39 | 139.28% | Michael Schmidt58% | $93 → $111 | Maintains | Buy | Get Alert |
| 12/03/2024 | RVMD | Buy Now | Revolution Medicines | $38.16 | 127.99% | Michael Schmidt58% | $82 → $87 | Maintains | Buy | Get Alert |
| 12/03/2024 | MRUS | Buy Now | Merus | $46.39 | 134.96% | Michael Schmidt58% | $111 → $109 | Reiterates | Buy → Buy | Get Alert |
| 11/15/2024 | ZNTL | Buy Now | Zentalis Pharma | $1.79 | 346.93% | Michael Schmidt58% | $12 → $8 | Maintains | Buy | Get Alert |
| 11/15/2024 | ADAP | Buy Now | Adaptimmune Therapeutics | $0.48 | 527.88% | Michael Schmidt58% | $4 → $3 | Maintains | Buy | Get Alert |
| 10/30/2024 | EXEL | Buy Now | Exelixis | $36.36 | -9.24% | Michael Schmidt58% | $32 → $33 | Maintains | Buy | Get Alert |
| 10/07/2024 | IMCR | Buy Now | Immunocore Hldgs | $28.38 | — | Michael Schmidt58% | — | Downgrade | Buy → Neutral | Get Alert |
| 09/30/2024 | VSTM | Buy Now | Verastem | $6.50 | 100% | Michael Schmidt58% | → $13 | Initiates | → Buy | Get Alert |
| 09/16/2024 | INCY | Buy Now | Incyte | $60.00 | 53.33% | Michael Schmidt58% | $86 → $92 | Maintains | Buy | Get Alert |
| 08/28/2024 | NBTX | Buy Now | Nanobiotix | $4.16 | 188.46% | Michael Schmidt58% | → $12 | Initiates | → Buy | Get Alert |
| 05/15/2024 | BOLT | Buy Now | Bolt Biotherapeutics | $0.40 | — | Michael Schmidt58% | — | Downgrade | Buy → Neutral | Get Alert |
| 04/30/2024 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Michael Schmidt58% | — | Downgrade | Buy → Neutral | Get Alert |
| 04/23/2024 | IMCR | Buy Now | Immunocore Hldgs | $28.38 | 224.23% | Michael Schmidt58% | $92 → $92 | Reiterates | Buy → Buy | Get Alert |
| 04/15/2024 | IMNM | Buy Now | Immunome | $8.50 | 311.76% | Michael Schmidt58% | → $35 | Initiates | → Buy | Get Alert |
| 04/05/2024 | ADCT | Buy Now | ADC Therapeutics | $1.83 | — | Michael Schmidt58% | — | Reiterates | → Buy | Get Alert |
| 03/28/2024 | ADCT | Buy Now | ADC Therapeutics | $1.83 | 501.09% | Michael Schmidt58% | → $11 | Initiates | → Buy | Get Alert |
| 03/14/2024 | IMRX | Buy Now | Immuneering | $1.68 | — | Michael Schmidt58% | — | Downgrade | Buy → Neutral | Get Alert |
| 02/29/2024 | MRSN | Buy Now | Mersana Therapeutics | $0.47 | 1392.54% | Michael Schmidt58% | → $7 | Upgrade | Neutral → Buy | Get Alert |
| 02/27/2024 | BGNE | Buy Now | BeiGene | — | — | Michael Schmidt58% | $350 → $345 | Maintains | Buy | Get Alert |
| 01/05/2024 | ALLO | Buy Now | Allogene Therapeutics | $1.69 | — | Michael Schmidt58% | — | Downgrade | Buy → Neutral | Get Alert |
| 12/04/2023 | INCY | Buy Now | Incyte | $60.00 | — | Michael Schmidt58% | — | Upgrade | Neutral → Buy | Get Alert |
| 12/01/2023 | IMGN | Buy Now | Immunogen | — | — | Michael Schmidt58% | $25 → $31 | Downgrade | Buy → Neutral | Get Alert |
| 11/08/2023 | XNCR | Buy Now | Xencor | $12.52 | 171.57% | Michael Schmidt58% | $40 → $34 | Maintains | Buy | Get Alert |
| 10/11/2023 | EXEL | Buy Now | Exelixis | $36.36 | -17.49% | Michael Schmidt58% | → $30 | Reiterates | Buy → Buy | Get Alert |
| 09/25/2023 | EXEL | Buy Now | Exelixis | $36.36 | -17.49% | Michael Schmidt58% | $27 → $30 | Maintains | Buy | Get Alert |
| 07/25/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $12.61 | 233.07% | Michael Schmidt58% | $40 → $42 | Maintains | Buy | Get Alert |
| 07/24/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | Michael Schmidt58% | $104 → $60 | Maintains | Buy | Get Alert |
| 07/11/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $12.61 | 217.21% | Michael Schmidt58% | → $40 | Initiates | → Buy | Get Alert |
| 06/27/2023 | ACET | Buy Now | Adicet Bio | $0.78 | 2463.12% | Michael Schmidt58% | → $20 | Downgrade | Buy → Neutral | Get Alert |
| 06/15/2023 | MRSN | Buy Now | Mersana Therapeutics | $0.47 | 2885.07% | Michael Schmidt58% | → $14 | Initiates | → Buy | Get Alert |
| 05/23/2023 | BPMC | Buy Now | Blueprint Medicines | $89.59 | -8.47% | Michael Schmidt58% | $78 → $82 | Maintains | Buy | Get Alert |
| 03/30/2023 | IMCR | Buy Now | Immunocore Hldgs | $28.38 | 199.56% | Michael Schmidt58% | → $85 | Initiates | → Buy | Get Alert |
| 03/21/2023 | ORIC | Buy Now | ORIC Pharmaceuticals | $7.63 | 96.59% | Michael Schmidt58% | → $15 | Downgrade | Buy → Neutral | Get Alert |
| 02/28/2023 | SGEN | Buy Now | Seagen | — | — | Michael Schmidt58% | → $170 | Reiterates | → Buy | Get Alert |
| 02/28/2023 | BGNE | Buy Now | BeiGene | — | — | Michael Schmidt58% | → $350 | Reiterates | → Buy | Get Alert |
| 01/20/2023 | BGNE | Buy Now | BeiGene | — | — | Michael Schmidt58% | $290 → $350 | Maintains | Buy | Get Alert |
| 01/12/2023 | ARVN | Buy Now | Arvinas | $8.36 | — | Michael Schmidt58% | — | Downgrade | Buy → Neutral | Get Alert |
| 01/04/2023 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Michael Schmidt58% | → $22 | Upgrade | Neutral → Buy | Get Alert |
| 01/03/2023 | ADAP | Buy Now | Adaptimmune Therapeutics | $0.48 | 946.46% | Michael Schmidt58% | → $5 | Upgrade | Neutral → Buy | Get Alert |
| 11/15/2022 | NLTX | Buy Now | Neoleukin Therapeutics | — | — | Michael Schmidt58% | — | Downgrade | Buy → Neutral | Get Alert |
| 11/11/2022 | ZNTL | Buy Now | Zentalis Pharma | $1.79 | 1464.25% | Michael Schmidt58% | $55 → $28 | Maintains | Buy | Get Alert |
| 10/13/2022 | BGNE | Buy Now | BeiGene | — | — | Michael Schmidt58% | → $205 | Upgrade | Neutral → Buy | Get Alert |
| 09/13/2022 | RUBY | Buy Now | Rubius Therapeutics | — | — | Michael Schmidt58% | — | Downgrade | Buy → Neutral | Get Alert |
| 08/03/2022 | INCY | Buy Now | Incyte | $60.00 | — | Michael Schmidt58% | — | Downgrade | Buy → Neutral | Get Alert |
| 05/20/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | Michael Schmidt58% | → $115 | Upgrade | Neutral → Buy | Get Alert |
| 04/11/2022 | RUBY | Buy Now | Rubius Therapeutics | — | — | Michael Schmidt58% | $25 → $5 | Maintains | Buy | Get Alert |
| 03/22/2022 | ORIC | Buy Now | ORIC Pharmaceuticals | $7.63 | — | Michael Schmidt58% | — | Downgrade | Buy → Neutral | Get Alert |
| 01/03/2022 | GMAB | Buy Now | Genmab | $20.20 | — | Michael Schmidt58% | — | Downgrade | Buy → Neutral | Get Alert |
| 12/06/2021 | ACET | Buy Now | Adicet Bio | $0.78 | 4000.99% | Michael Schmidt58% | $22 → $32 | Maintains | Buy | Get Alert |
| 08/24/2021 | IMRX | Buy Now | Immuneering | $1.68 | 2400% | Michael Schmidt58% | → $42 | Initiates | → Buy | Get Alert |
| 08/10/2021 | ERAS | Buy Now | Erasca | $1.40 | 1685.71% | Michael Schmidt58% | → $25 | Initiates | → Buy | Get Alert |
| 07/19/2021 | GLUE | Buy Now | Monte Rosa Therapeutics | $6.67 | 349.78% | Michael Schmidt58% | → $30 | Initiates | → Buy | Get Alert |
| 05/18/2021 | RAIN | Buy Now | Rain Oncology | $1.95 | 1233.33% | Michael Schmidt58% | → $26 | Initiates | → Buy | Get Alert |
| 04/28/2021 | CLLS | Buy Now | Cellectis | $1.24 | — | Michael Schmidt58% | — | Downgrade | Buy → Neutral | Get Alert |
| 04/08/2021 | ACET | Buy Now | Adicet Bio | $0.78 | 2719.43% | Michael Schmidt58% | → $22 | Initiates | → Buy | Get Alert |
| 03/02/2021 | BOLT | Buy Now | Bolt Biotherapeutics | $0.40 | 10506.06% | Michael Schmidt58% | → $42 | Initiates | → Buy | Get Alert |
| 05/19/2020 | ORIC | Buy Now | ORIC Pharmaceuticals | $7.63 | 489.78% | Michael Schmidt58% | → $45 | Initiates | → Buy | Get Alert |
| 05/01/2020 | SGEN | Buy Now | Seagen | — | — | Michael Schmidt58% | — | Upgrade | Neutral → Buy | Get Alert |
| 04/28/2020 | ZNTL | Buy Now | Zentalis Pharma | $1.79 | 2413.97% | Michael Schmidt58% | → $45 | Initiates | → Buy | Get Alert |
| 04/23/2020 | IMMU | Buy Now | Immunomedics | — | — | Michael Schmidt58% | $35 → $39 | Maintains | Buy | Get Alert |
| 03/09/2020 | RVMD | Buy Now | Revolution Medicines | $38.16 | 31.03% | Michael Schmidt58% | → $50 | Initiates | → Buy | Get Alert |
| 02/25/2020 | XNCR | Buy Now | Xencor | $12.52 | 243.45% | Michael Schmidt58% | → $43 | Upgrade | Neutral → Buy | Get Alert |
| 02/18/2020 | NLTX | Buy Now | Neoleukin Therapeutics | — | — | Michael Schmidt58% | → $400 | Initiates | → Buy | Get Alert |
| 01/02/2020 | SGEN | Buy Now | Seagen | — | — | Michael Schmidt58% | — | Downgrade | Buy → Neutral | Get Alert |
| 01/02/2020 | INCY | Buy Now | Incyte | $60.00 | — | Michael Schmidt58% | — | Downgrade | Buy → Neutral | Get Alert |
| 12/27/2019 | SPPI | Buy Now | Spectrum Pharma | — | — | Michael Schmidt58% | — | Downgrade | Buy → Neutral | Get Alert |
| 12/11/2019 | FTSV | Buy Now | Forty Seven | — | — | Michael Schmidt58% | $20 → $48 | Maintains | Buy | Get Alert |
| 09/24/2019 | MRTX | Buy Now | Mirati Therapeutics | — | — | Michael Schmidt58% | — | Upgrade | Neutral → Buy | Get Alert |
| 08/12/2019 | GMAB | Buy Now | Genmab | $20.20 | — | Michael Schmidt58% | — | Initiates | → Buy | Get Alert |
| 08/07/2019 | XNCR | Buy Now | Xencor | $12.52 | — | Michael Schmidt58% | — | Downgrade | Buy → Neutral | Get Alert |
| 06/07/2019 | MRTX | Buy Now | Mirati Therapeutics | — | — | Michael Schmidt58% | — | Downgrade | Buy → Neutral | Get Alert |
| 05/31/2019 | RUBY | Buy Now | Rubius Therapeutics | — | — | Michael Schmidt58% | → $25 | Initiates | → Buy | Get Alert |
| 05/13/2019 | SPPI | Buy Now | Spectrum Pharma | — | — | Michael Schmidt58% | → $19 | Initiates | → Buy | Get Alert |
| 04/12/2019 | FTSV | Buy Now | Forty Seven | — | — | Michael Schmidt58% | — | Initiates | → Buy | Get Alert |
| 04/12/2019 | XNCR | Buy Now | Xencor | $12.52 | 235.46% | Michael Schmidt58% | → $42 | Initiates | → Buy | Get Alert |
| 03/05/2019 | BLUE | Buy Now | bluebird bio | $3.94 | — | Michael Schmidt58% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 02/15/2019 | AGIO | Buy Now | Agios Pharmaceuticals | $31.20 | 156.41% | Michael Schmidt58% | → $80 | Upgrade | Market Perform → Outperform | Get Alert |
| 01/17/2019 | ARRY | Buy Now | Array Technologies | $6.25 | — | Michael Schmidt58% | — | Initiates | → Outperform | Get Alert |
| 11/28/2018 | BLUE | Buy Now | bluebird bio | $3.94 | 3580.2% | Michael Schmidt58% | → $2900 | Initiates | → Outperform | Get Alert |
| 10/29/2018 | MRTX | Buy Now | Mirati Therapeutics | — | — | Michael Schmidt58% | — | Upgrade | Neutral → Buy | Get Alert |
| 09/25/2018 | CLVS | Buy Now | Clovis Oncology | — | — | Michael Schmidt58% | → $30 | Initiates | → Market Perform | Get Alert |
| 09/25/2018 | AGIO | Buy Now | Agios Pharmaceuticals | $31.20 | 156.41% | Michael Schmidt58% | → $80 | Initiates | → Market Perform | Get Alert |
| 09/13/2018 | FPRX | Buy Now | Five Prime Therapeutics | — | — | Michael Schmidt58% | → $24 | Reinstates | → Outperform | Get Alert |
| 03/16/2018 | CLLS | Buy Now | Cellectis | $1.24 | — | Michael Schmidt58% | — | Initiates | → Neutral | Get Alert |
| 02/07/2018 | ARRY | Buy Now | Array Technologies | $6.25 | 220% | Michael Schmidt58% | $19 → $20 | Maintains | Outperform | Get Alert |
| 01/25/2018 | BLUE | Buy Now | bluebird bio | $3.94 | — | Michael Schmidt58% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 01/23/2018 | JUNO | Buy Now | Juno Therapeutics | — | — | Michael Schmidt58% | $56 → $87 | Downgrade | Outperform → Market Perform | Get Alert |
| 01/22/2018 | ARRY | Buy Now | Array Technologies | $6.25 | — | Michael Schmidt58% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 11/14/2017 | MRTX | Buy Now | Mirati Therapeutics | — | — | Michael Schmidt58% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 11/07/2017 | ABUS | Buy Now | Arbutus Biopharma | $3.25 | 69.23% | Michael Schmidt58% | $4 → $5.5 | Maintains | Market Perform | Get Alert |
| 11/02/2017 | JUNO | Buy Now | Juno Therapeutics | — | — | Michael Schmidt58% | $34 → $56 | Maintains | Outperform | Get Alert |
| 09/22/2017 | EXEL | Buy Now | Exelixis | $36.36 | — | Michael Schmidt58% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 09/15/2017 | MRTX | Buy Now | Mirati Therapeutics | — | — | Michael Schmidt58% | $7 → $9 | Maintains | Market Perform | Get Alert |
| 08/02/2017 | AGIO | Buy Now | Agios Pharmaceuticals | $31.20 | — | Michael Schmidt58% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 06/13/2017 | CLVS | Buy Now | Clovis Oncology | — | — | Michael Schmidt58% | → $85 | Initiates | → Outperform | Get Alert |
| 01/30/2017 | ARRY | Buy Now | Array Technologies | $6.25 | — | Michael Schmidt58% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 11/28/2016 | JUNO | Buy Now | Juno Therapeutics | — | — | Michael Schmidt58% | $45 → $34 | Maintains | Outperform | Get Alert |
| 08/05/2016 | ABUS | Buy Now | Arbutus Biopharma | $3.25 | — | Michael Schmidt58% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 03/10/2016 | MRTX | Buy Now | Mirati Therapeutics | — | — | Michael Schmidt58% | $50 → $37 | Maintains | Outperform | Get Alert |
| 02/03/2016 | BLUE | Buy Now | bluebird bio | $3.94 | 1600.51% | Michael Schmidt58% | → $1340 | Initiates | → Outperform | Get Alert |
| 01/19/2016 | EXEL | Buy Now | Exelixis | $36.36 | — | Michael Schmidt58% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 12/07/2015 | AGIO | Buy Now | Agios Pharmaceuticals | $31.20 | — | Michael Schmidt58% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 05/08/2015 | MRTX | Buy Now | Mirati Therapeutics | — | — | Michael Schmidt58% | $27 → $35 | Maintains | Outperform | Get Alert |
| 03/12/2015 | MRTX | Buy Now | Mirati Therapeutics | — | — | Michael Schmidt58% | $25 → $27 | Maintains | Outperform | Get Alert |
| 01/23/2015 | FPRX | Buy Now | Five Prime Therapeutics | — | — | Michael Schmidt58% | → $35 | Initiates | → Outperform | Get Alert |
| 01/22/2015 | FPRX | Buy Now | Five Prime Therapeutics | — | — | Michael Schmidt58% | → $35 | Initiates | → Outperform | Get Alert |
| 01/13/2015 | JUNO | Buy Now | Juno Therapeutics | — | — | Michael Schmidt58% | → $74 | Initiates | → Outperform | Get Alert |
| 08/13/2014 | ARRY | Buy Now | Array Technologies | $6.25 | -4% | Michael Schmidt58% | $8 → $6 | Maintains | Outperform | Get Alert |
| 05/02/2014 | EXEL | Buy Now | Exelixis | $36.36 | -87.62% | Michael Schmidt58% | $5 → $4.5 | Maintains | Market Perform | Get Alert |
| 01/28/2014 | EXEL | Buy Now | Exelixis | $36.36 | -80.75% | Michael Schmidt58% | → $7 | Initiates | → Market Perform | Get Alert |
| 08/19/2013 | AGIO | Buy Now | Agios Pharmaceuticals | $31.20 | 21.79% | Michael Schmidt58% | → $38 | Initiates | → Outperform | Get Alert |
| 08/15/2012 | ARRY | Buy Now | Array Technologies | $6.25 | — | Michael Schmidt58% | — | Upgrade | Market Perform → Outperform | Get Alert |
